UROLOGY FACTOR SOLUTIONS LTD

Company number 14397640 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

UROLOGY FACTOR SOLUTIONS LTD - Analysis Report

Company Number: 14397640

Analysis Date: 2025-07-20 11:32 UTC

Financial Health Assessment for UROLOGY FACTOR SOLUTIONS LTD


1. Financial Health Score: C

Explanation:
The company is in its early stage, with a small but positive equity base (£29,780) and no reported liabilities, indicating a healthy initial balance sheet. However, the absence of turnover data and profits, as well as no employees beyond the director, suggests the business is in its infancy or dormant operationally. This score reflects a stable but nascent financial condition requiring growth and operational momentum to improve.


2. Key Vital Signs

Metric Value (£) Interpretation
Net Current Assets 29,780 Positive working capital; indicates liquidity buffer.
Cash at Bank 29,780 Healthy cash flow position relative to size.
Net Assets 29,780 Entirely equity financed; no debt burden.
Turnover Not disclosed No revenue data; possibly minimal or no sales yet.
Employees 0 No staff beyond director; suggests low operational activity.

Interpretation:

  • The "vital sign" of cash and net current assets are healthy with no current liabilities, reflecting a stable financial base.
  • Absence of turnover "symptom" may indicate the company is in setup phase or has not yet commenced significant trading.
  • No employees besides the director could signal low operational scale or outsourcing of services.

3. Diagnosis

The financial snapshot resembles a patient in the early stages of life—capitalized but not yet active in generating income or incurring material expenses. The positive cash balance and no liabilities are a sign of stable "health" but the lack of trading activity and employees suggest the business is not yet fully "awake" or operational.

This condition is typical for a recently incorporated company (since October 2022), particularly in specialist medical practice where setup and regulatory compliance may precede significant revenue generation. The absence of audit requirements and limited financial disclosures align with the company’s small size and early stage.


4. Recommendations

  • Accelerate Revenue Generation: Develop and execute a clear business plan to transition from setup to active trading, aiming to generate turnover and demonstrate operational viability.
  • Cash Flow Monitoring: Maintain vigilant cash flow management to ensure the "healthy circulation" of funds, avoiding liquidity strain as operations scale.
  • Operational Capacity: Consider hiring or contracting necessary staff to expand service delivery capacity and support business growth.
  • Financial Reporting: Prepare for fuller financial reporting as the company grows, including turnover and profit and loss accounts, to provide stakeholders with comprehensive health indicators.
  • Strategic Planning: Use the initial financial stability as a solid foundation to seek investment or financing if growth requires external capital infusion.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.